Alexion ends Moderna mRNA pact

By Flora Southey

Alexion Pharmaceuticals says it is reducing R&D operations and terminating mRNA-focused preclinical partnerships.

The facility combines Covance Drug Development and LabCorp Diagnostics capabilities. (Photo: Business Wire)

Covance opens companion diagnostics laboratory

By Melissa Fassbender

LabCorp’s Covance has opened a new companion diagnostics laboratory as is prepares for an increasing demand for precision medicine – a market expected to reach $112.62bn by 2025.

(Image: iStock/sudok1)

LabCorp completes acquisition of PAML

By Melissa Fassbender

LabCorp has completed its acquisition of Pathology Associates Medical Laboratories (PAML), which will be integrated into its national network of regional and specialty laboratories.


Follow us


View more


Featured Suppliers

All suppliers